Accessibility: Skip TopNav
Comparison of the 24-month DDAF lesion growth between Tinlarebant-treated subjects and ProgStar participants
Comparison of the 24-month DDAF lesion growth between Tinlarebant-treated subjects and ProgStar participants
Format
PNG
Source
Belite Bio, Inc
Downloads
Original
Large
Medium
Small